News & Analysis as of

Life Sciences Sale of Assets

WilmerHale

Royalty Financings and Similar Revenue Monetizations Surge in Difficult Life Sciences Fundraising Environment

WilmerHale on

Many biopharmaceutical companies are facing challenges raising cash through traditional equity markets. While venture investment activity saw a slight increase in the first half of 2024 as compared to the equivalent period in...more

Skadden, Arps, Slate, Meagher & Flom LLP

"Two Court of Chancery Deal Litigation Decisions Provide Helpful Guidance"

Chelsea Therapeutics: Post-Closing Bad Faith Claim a ‘Rare Bird’ in Delaware Absent Allegations of Self-Interestedness or Lack of Independence - In In re Chelsea Therapeutics International LTD Stockholders Litigation,...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: MTS Health Sells DNA Diagnostics Center to GHO Capital for $110 Million

McGuireWoods LLP on

MTS Health Investors has announced it has sold portfolio company DNA Diagnostics Center (DDC) to GHO Capital Partners for $110 million. DDC, based in Fairfield, Ohio, provides DNA testing services in three main areas:...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide